Literature DB >> 12794847

Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al.

Angel Garcia Aparicio, Santiago Muñoz-Fernández, Gema Bonilla, Ambrosio Miralles, Victor Cerdeño, Emilio Martín-Mola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794847     DOI: 10.1002/art.11019

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

Review 2.  Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature.

Authors:  Georg Schett; Petra Herak; Winfried Graninger; Josef S Smolen; Martin Aringer
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

4.  Listeriosis in a Metropolitan Hospital: Is Targeted Therapy a Risk Factor for Infection?

Authors:  Fanfan Xing; Simon K F Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Front Med (Lausanne)       Date:  2022-04-29

5.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

6.  Novel immunobiologics for psoriasis.

Authors:  Nilanjan Ghosh; P N Singh; Vikas Kumar
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.